From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast – today's news is a £240m damning of Neil Woodford's greed and wickedness

By Tom Winnifrith | Monday 6 June 2022


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


It is just five days to Rogue Bloggers for Woodlarks and we are at just under 33% of our target so can the 93% of listeners yet to donate please do so HERE. In today's podcast I cover the quarter of a billion quid blown, largely by Neil Woodford, at Rutherford (RUTH) and how that made Woodford,personally, even richer. I name and shame a couple of those who enabled that scam.  I look at Wildcat Petroleum (WCAT), Guild ESports (GILD) and Cellular Goods (CBX) and the piss poor Times' idea of breaking news, I mention Optibiotix (OPTI),look at Eve (EVE) which seems to be a zero to me, at spineless and busted Cineworld (CINE) and in detail at ADVFN (AFN) and its woes.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:30:27